More than two centuries after the last blue antelope disappeared from the Cape of South Africa, a Dallas biotechnology company is attempting to reverse that loss using preserved museum DNA and the tools of genomic editing. Colossal Biosciences, already known for its efforts to revive the woolly mammoth and the dire wolf, has entered the active phase of reconstructing the bluebuck's genome, with surrogate births projected within years. The project forces a quiet reckoning with what humanity owes to species it erased, and whether science can truly restore what history has undone — or only approx
Biotech firm aims to resurrect extinct blue antelope using museum DNA and gene editing
Cobertura Relacionada
Restos mortais de dois belgas desaparecidos em 1992 foram encontrados nos Alpes suíços após derretimento de geleira. Des…
Google News · Aug 19 NASA encontra “criatura” misteriosa em Marte e imagem reacende teorias sobre vida fora da Terra - diariodocomercio.com.bImagem de rover da NASA em Marte reaviva especulações sobre possível vida extraterrestre, embora agência não tenha confi…
Diário do Comércio · Aug 19 Imagem de Marte da Nasa reacende teorias sobre vida extraterrestreImagem do robô Curiosity da Nasa em Marte viralizou nas redes sociais com objeto misterioso que internautas associaram a…
CNN Portugal · Aug 19 Satélite da NASA capta cratera de 18 metros causada por foguetão SpaceX na LuaSatélite da NASA captura imagens de uma cratera de 18 metros formada pelo impacto de um andar superior de um foguetão Fa…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
US biotech firm's de-extinction project of African blue antelope raises geopolitical questions about genetic sovereignty, biodiversity stewardship, and resource access involving South African and Swedish genetic materials.
Reflects asymmetric biotechnology power: US private capital controls genetic resurrection of African species using museum specimens from European institutions, potentially establishing precedent for genetic IP ownership over extinct species and raising questions about African nations' sovereignty over their historical biodiversity.
Similar to colonial-era specimen extraction; now genetic material from European museums and African species are being leveraged by US biotech firms, echoing historical resource extraction patterns but in biotechnology domain.
Lente Económico
Biotech de-extinction project has minimal direct economic impact on energy/commodities sectors but signals growing biotech investment and potential future applications in agriculture and conservation biotechnology.
Limited immediate consumer impact. Long-term potential benefits include advances in genetic technologies applicable to food production, disease resistance in livestock, and conservation methods. Possible future costs if de-extinction becomes commercialized.
Governments may need to establish regulatory frameworks for de-extinction projects, genetic modification ethics, wildlife reintroduction protocols, and intellectual property rights for synthetic organisms. International coordination required for cross-border species management and conservation standards.